{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T16:35:48Z","timestamp":1786379748873,"version":"build-2736575974"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1093\/rheumatology\/ket233","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T04:44:16Z","timestamp":1373431456000},"page":"1845-1855","source":"Crossref","is-referenced-by-count":32,"title":["The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis"],"prefix":"10.1093","volume":"52","author":[{"given":"Daniel E.","family":"Furst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Chester","family":"Wasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Keystone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick T.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette H.","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob U.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mittie K.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"key\n\t\t\t\t20170225063752_ket233-B1","doi-asserted-by":"crossref","first-page":"50S","DOI":"10.1016\/j.amjmed.2003.12.012","article-title":"Prevalence and outcomes of anemia in rheumatoid arthritis: a systematic review of the literature","volume":"116","author":"Wilson","year":"2004","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20170225063752_ket233-B2","first-page":"1516","article-title":"Anemia and renal function in patients with rheumatoid arthritis","volume":"33","author":"Wolfe","year":"2006","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B3","first-page":"2177","article-title":"Association of anemia and physical disability among patients with rheumatoid arthritis","volume":"34","author":"Han","year":"2007","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170225063752_ket233-B5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1182\/blood-2002-01-0136","article-title":"Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-\u03b1 antibody therapy","volume":"100","author":"Papadaki","year":"2002","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170225063752_ket233-B6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00062752-200503000-00001","article-title":"Anemia of inflammation: the hepcidin link","volume":"12","author":"Roy","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI200420945","article-title":"IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin","volume":"113","author":"Nemeth","year":"2004","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170225063752_ket233-B8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2362.1992.tb01495.x","article-title":"Tumor necrosis factor alpha is associated with disease activity and the degree of anemia in patients with rheumatoid arthritis","volume":"22","author":"Vreugdenhil","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"key\n\t\t\t\t20170225063752_ket233-B9","first-page":"1504","article-title":"Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease","volume":"24","author":"Jongen-Lavrencic","year":"1997","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B10","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/rheumatology\/36.9.950","article-title":"Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor \u03b1 blockade","volume":"36","author":"Davis","year":"1997","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semarthrit.2008.08.002","article-title":"Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures\u2014a pooled analysis from three large, multicenter, double-blind, randomized clinical trials","volume":"39","author":"Doyle","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225063752_ket233-B12","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.24638","article-title":"Golimumab, a human anti-tumor necrosis factor \u03b1 monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis","volume":"60","author":"Emery","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225063752_ket233-B13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/ard.2008.099010","article-title":"Golimumab, a human antibody to tumour necrosis factor \u03b1 given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study","volume":"68","author":"Keystone","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225063752_ket233-B14","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(09)60506-7","article-title":"Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial","volume":"374","author":"Smolen","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170225063752_ket233-B15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","article-title":"Golimumab, a new human tumor necrosis factor \u03b1 antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study","volume":"60","author":"Kavanaugh","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225063752_ket233-B16","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/art.23969","article-title":"Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial","volume":"58","author":"Inman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225063752_ket233-B17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225063752_ket233-B18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/rheumatology\/35.11.1101","article-title":"Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score","volume":"35","author":"Prevoo","year":"1996","journal-title":"Br J Rheumatol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B19","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","article-title":"Validation of rheumatoid arthritis improvement criteria that include simplified joint counts","volume":"41","author":"van Gestel","year":"1998","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20170225063752_ket233-B20","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/clim.2002.5191","article-title":"Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease","volume":"103","author":"Shanahan","year":"2002","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20170225063752_ket233-B22","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1136\/ard.2010.146043","article-title":"Changes in patient characteristics in anti-tumor necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years","volume":"70","author":"Rahman","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225063752_ket233-B23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/ard.49.2.93","article-title":"Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness","volume":"49","author":"Vreugdenhil","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20170225063752_ket233-B24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","article-title":"Ferritin in autoimmune diseases","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"key":"key\n\t\t\t\t20170225063752_ket233-B25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2169\/internalmedicine.48.1578","article-title":"Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis","volume":"48","author":"Demirag","year":"2009","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t20170225063752_ket233-B26","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/art.11104","article-title":"Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial","volume":"48","author":"Braun","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/52\/10\/1845\/10652961\/ket233.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T04:37:21Z","timestamp":1503549441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/1792810\/The"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,7,9]]},"published-print":{"date-parts":[[2013,10]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/ket233","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}